Literature DB >> 20713647

Standard operating procedures for describing and performing metabolic tests of glucose homeostasis in mice.

Julio E Ayala1, Varman T Samuel, Gregory J Morton, Silvana Obici, Colleen M Croniger, Gerald I Shulman, David H Wasserman, Owen P McGuinness.   

Abstract

The Mouse Metabolic Phenotyping Center (MMPC) Consortium was established to address the need to characterize the growing number of mouse models of metabolic diseases, particularly diabetes and obesity. A goal of the MMPC Consortium is to propose standard methods for assessing metabolic phenotypes in mice. In this article, we discuss issues pertaining to the design and performance of various tests of glucose metabolism. We also propose guidelines for the description of methods, presentation of data and interpretation of results. The recommendations presented in this article are based on the experience of the MMPC Consortium and other investigators.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20713647      PMCID: PMC2938392          DOI: 10.1242/dmm.006239

Source DB:  PubMed          Journal:  Dis Model Mech        ISSN: 1754-8403            Impact factor:   5.758


  61 in total

1.  Differential effects of rosiglitazone on skeletal muscle and liver insulin resistance in A-ZIP/F-1 fatless mice.

Authors:  Jason K Kim; Jonathan J Fillmore; Oksana Gavrilova; Lily Chao; Takamasa Higashimori; Hyejeong Choi; Hyo-Jeong Kim; Chunli Yu; Yan Chen; Xianqin Qu; Martin Haluzik; Marc L Reitman; Gerald I Shulman
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

2.  Glucose toxicity and the development of diabetes in mice with muscle-specific inactivation of GLUT4.

Authors:  J K Kim; A Zisman; J J Fillmore; O D Peroni; K Kotani; P Perret; H Zong; J Dong; C R Kahn; B B Kahn; G I Shulman
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

3.  Heterogeneous metabolic adaptation of C57BL/6J mice to high-fat diet.

Authors:  Rémy Burcelin; Valérie Crivelli; Anabela Dacosta; Alexandra Roy-Tirelli; Bernard Thorens
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-04       Impact factor: 4.310

Review 4.  Phasic insulin release and metabolic regulation in type 2 diabetes.

Authors:  Stefano Del Prato; Piero Marchetti; Riccardo C Bonadonna
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

5.  Opposite effects of background genotype on muscle and liver insulin sensitivity of lipoatrophic mice. Role of triglyceride clearance.

Authors:  Carlo Colombo; Martin Haluzik; Jaime J Cutson; Kelly R Dietz; Bernice Marcus-Samuels; Charles Vinson; Oksana Gavrilova; Marc L Reitman
Journal:  J Biol Chem       Date:  2002-11-26       Impact factor: 5.157

6.  Insulin resistance in tetracycline-repressible Munc18c transgenic mice.

Authors:  Beth A Spurlin; Rhonda M Thomas; Angela K Nevins; Hyo-Jeong Kim; Yoon-Jung Kim; Hye-Lim Noh; Gerald I Shulman; Jason K Kim; Debbie C Thurmond
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

Review 7.  NIH experiment in centralized mouse phenotyping: the Vanderbilt experience and recommendations for evaluating glucose homeostasis in the mouse.

Authors:  Owen P McGuinness; Julio E Ayala; Maren R Laughlin; David H Wasserman
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-07-28       Impact factor: 4.310

8.  Impact of genetic background on development of hyperinsulinemia and diabetes in insulin receptor/insulin receptor substrate-1 double heterozygous mice.

Authors:  Rohit N Kulkarni; Katrine Almind; H Joseph Goren; Jonathon N Winnay; Kohjiro Ueki; Terumasa Okada; C Ronald Kahn
Journal:  Diabetes       Date:  2003-06       Impact factor: 9.461

9.  Adrenalectomy improves diabetes in A-ZIP/F-1 lipoatrophic mice by increasing both liver and muscle insulin sensitivity.

Authors:  Martin Haluzik; Kelly R Dietz; Jason K Kim; Bernice Marcus-Samuels; Gerald I Shulman; Oksana Gavrilova; Marc L Reitman
Journal:  Diabetes       Date:  2002-07       Impact factor: 9.461

10.  Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis.

Authors:  Hyunsook Kim; Martin Haluzik; Zeenat Asghar; Daphne Yau; Jamie W Joseph; Ana M Fernandez; Marc L Reitman; Shoshana Yakar; Bethel Stannard; Lisa Heron-Milhavet; Michael B Wheeler; Derek LeRoith
Journal:  Diabetes       Date:  2003-07       Impact factor: 9.461

View more
  297 in total

1.  Estrogen receptor-α signaling maintains immunometabolic function in males and is obligatory for exercise-induced amelioration of nonalcoholic fatty liver.

Authors:  Nathan C Winn; Thomas J Jurrissen; Zachary I Grunewald; Rory P Cunningham; Makenzie L Woodford; Jill A Kanaley; Dennis B Lubahn; Camila Manrique-Acevedo; R Scott Rector; Victoria J Vieira-Potter; Jaume Padilla
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-12-04       Impact factor: 4.310

2.  Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance.

Authors:  François R Jornayvaz; Hui-Young Lee; Michael J Jurczak; Tiago C Alves; Fitsum Guebre-Egziabher; Blas A Guigni; Dongyan Zhang; Varman T Samuel; J Enrique Silva; Gerald I Shulman
Journal:  Endocrinology       Date:  2011-12-06       Impact factor: 4.736

3.  Sleeve gastrectomy leads to weight loss in the Magel2 knockout mouse.

Authors:  Deanna M Arble; Joshua W Pressler; Joyce Sorrell; Rachel Wevrick; Darleen A Sandoval
Journal:  Surg Obes Relat Dis       Date:  2016-04-27       Impact factor: 4.734

4.  Placensin is a glucogenic hormone secreted by human placenta.

Authors:  Yiping Yu; Jia-Huan He; Lin-Li Hu; Lin-Lin Jiang; Lanlan Fang; Gui-Dong Yao; Si-Jia Wang; Qingling Yang; Yanjie Guo; Lin Liu; Trisha Shang; Yorino Sato; Kazuhiro Kawamura; Aaron Jw Hsueh; Ying-Pu Sun
Journal:  EMBO Rep       Date:  2020-04-24       Impact factor: 8.807

5.  The Diabetes Gene and Wnt Pathway Effector TCF7L2 Regulates Adipocyte Development and Function.

Authors:  Xi Chen; Iriscilla Ayala; Chris Shannon; Marcel Fourcaudot; Nikhil K Acharya; Christopher P Jenkinson; Sami Heikkinen; Luke Norton
Journal:  Diabetes       Date:  2018-01-09       Impact factor: 9.461

6.  Exposure to p,p'-dichlorodiphenyldichloroethylene (DDE) induces fasting hyperglycemia without insulin resistance in male C57BL/6H mice.

Authors:  George E Howell; Edward Meek; Jessica Kilic; Mariel Mohns; Charlee Mulligan; Janice E Chambers
Journal:  Toxicology       Date:  2014-02-26       Impact factor: 4.221

7.  Tpcn2 knockout mice have improved insulin sensitivity and are protected against high-fat diet-induced weight gain.

Authors:  Hong He; Katie Holl; Sarah DeBehnke; Chay Teng Yeo; Polly Hansen; Abraham K Gebre; Sandra Leone-Kabler; Margarida Ruas; John S Parks; John Parrington; Leah C Solberg Woods
Journal:  Physiol Genomics       Date:  2018-05-11       Impact factor: 3.107

8.  Short-term food restriction followed by controlled refeeding promotes gorging behavior, enhances fat deposition, and diminishes insulin sensitivity in mice.

Authors:  Kara L Kliewer; Jia-Yu Ke; Hui-Young Lee; Michael B Stout; Rachel M Cole; Varman T Samuel; Gerald I Shulman; Martha A Belury
Journal:  J Nutr Biochem       Date:  2015-03-13       Impact factor: 6.048

9.  High-Fat-Diet-Induced Deficits in Dopamine Terminal Function Are Reversed by Restoring Insulin Signaling.

Authors:  Steve C Fordahl; Sara R Jones
Journal:  ACS Chem Neurosci       Date:  2017-01-03       Impact factor: 4.418

10.  Low-Dose Dihydrotestosterone Drives Metabolic Dysfunction via Cytosolic and Nuclear Hepatic Androgen Receptor Mechanisms.

Authors:  Stanley Andrisse; Shameka Childress; Yaping Ma; Katelyn Billings; Yi Chen; Ping Xue; Ashley Stewart; Momodou L Sonko; Andrew Wolfe; Sheng Wu
Journal:  Endocrinology       Date:  2017-03-01       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.